REPAGLINIDE TABLETS

Clinical trials for REPAGLINIDE TABLETS explained in plain language.

Never miss a new study

Get alerted when new REPAGLINIDE TABLETS trials appear

Sign up with your email to follow new studies for REPAGLINIDE TABLETS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test new Shot's safety with common pills

Knowledge-focused Completed

This early study aimed to see if a new injectable drug called Y-3 interacts with three common oral medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Researchers enrolled 24 healthy Chinese participants to measure how the body pro…

Matched conditions: REPAGLINIDE TABLETS

Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:30 UTC

REPAGLINIDE TABLETS

Get alerted when new REPAGLINIDE TABLETS trials appear

Scientists test new Shot's safety with common pills